DaVita HealthCare Partners Inc (DVA)

Working capital turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 12,140,150 11,911,290 11,738,650 11,665,040 11,609,900 11,636,980 11,626,610 11,616,360 11,618,800 11,580,150 11,565,900 11,529,370 11,550,610 11,543,870 11,523,880 11,486,600 11,388,470 11,311,010 11,254,260 11,298,510
Total current assets US$ in thousands 3,137,910 3,135,360 3,001,970 3,039,740 3,155,290 3,202,440 3,264,110 3,128,710 3,167,720 3,839,540 3,978,590 3,866,680 3,148,720 3,429,680 5,779,830 4,023,940 3,690,170 3,998,720 6,390,630 9,225,080
Total current liabilities US$ in thousands 2,642,210 2,537,930 2,403,420 2,565,090 2,619,750 2,537,410 2,310,750 2,420,450 2,398,530 2,363,050 2,386,040 2,314,720 2,476,140 2,499,240 4,274,560 2,220,750 2,372,100 2,206,640 5,706,940 8,230,880
Working capital turnover 24.49 19.94 19.61 24.58 21.68 17.50 12.20 16.40 15.11 7.84 7.26 7.43 17.17 12.41 7.66 6.37 8.64 6.31 16.46 11.36

December 31, 2023 calculation

Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $12,140,150K ÷ ($3,137,910K – $2,642,210K)
= 24.49

The working capital turnover of DaVita Inc has shown fluctuations over the past eight quarters. The ratio peaked in Q4 2023 at 24.49, indicating that DaVita Inc generated $24.49 in revenue for every dollar of working capital invested during that period. This increase from the previous quarter suggests an improvement in the efficiency of using working capital to generate revenue.

However, the working capital turnover in Q3 and Q2 2023, as well as in Q4 and Q3 2022, was lower compared to Q4 2023. This indicates that DaVita Inc was less efficient in utilizing its working capital to generate revenue during those quarters.

Overall, the trend in working capital turnover suggests some variability in how efficiently DaVita Inc is utilizing its working capital to generate revenue, with Q4 2023 standing out as a particularly strong period in this regard. Further analysis of the company's operations and financial performance may be needed to understand the factors influencing these fluctuations in working capital turnover.


Peer comparison

Dec 31, 2023

Company name
Symbol
Working capital turnover
DaVita HealthCare Partners Inc
DVA
24.49
Progyny Inc
PGNY
2.40
Sotera Health Co
SHC
3.21